Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059397 · ClinicalTrials.gov registry record
Hepatitis C: Grading and Staging by MR
A clinical trial of Hepatitis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT00059397 is a study of Hepatitis that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 80 participants, below the 254-participant average among 5 other Hepatitis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00059397, a study of Hepatitis, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
Conditions Studied
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059397
The ClinicalTrials.gov registry entry for NCT00059397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 5 other Hepatitis trials with a reported enrollment target (69% lower). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis appearing as the primary indexed condition, and to 0 interventions.
NCT00059397 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00059397 about?
NCT00059397 is a clinical study titled "Hepatitis C: Grading and Staging by MR". To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
What is the current status of trial NCT00059397?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2003-04.
What conditions does trial NCT00059397 study?
This clinical trial studies the following conditions: Hepatitis.
Who is sponsoring clinical trial NCT00059397?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00059397 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
RECRUITING · Phase 3
-
Treating Nonalcoholic Steatohepatitis With Pioglitazone
COMPLETED · Phase 2
-
Manhattan HIV/Hepatology Brain Bank
COMPLETED
-
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
COMPLETED · Phase 2
-
The Health Access and Recovery Peer Program
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.